Dissemin is shutting down on January 1st, 2025

Published in

Lippincott, Williams & Wilkins, Current Opinion in Neurology, 3(23), p. 226-233, 2010

DOI: 10.1097/wco.0b013e3283398c96

Links

Tools

Export citation

Search in Google Scholar

Demyelination as a complication of new immunomodulatory treatments.

Journal article published in 2010 by Andreas P. Lysandropoulos, Renaud A. Du Pasquier ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

This review discusses demyelinating events of the nervous system that have been associated with new immunomodulatory treatments, in particular monoclonal antibodies (mAbs). ; Journal Article ; Research Support, Non-U.S. Gov't ; Review ; info:eu-repo/semantics/published